|
Exelixis's Promising Pipeline Of Drugs
|
|
Exelixis
|
Mar 18, 2013 11:59AM
|
|
Excellent read
|
1
|
Mannkind
|
Aug 24, 2013 06:36PM
|
|
European submission
|
3
|
Mannkind
|
Jul 17, 2013 11:20AM
|
|
Eli Lilly And The State Of The Insulin Battle
|
1
|
Mannkind
|
Oct 08, 2012 08:07PM
|
|
Earnings call transcript
|
1
|
Mannkind
|
May 09, 2012 10:23PM
|
|
Earnings call
|
|
Mannkind
|
Oct 22, 2012 06:54PM
|
|
Dreamboat Assy
|
|
Mannkind
|
Apr 25, 2012 09:05PM
|
|
Don’t Sweat MannKind Corporation’s (MNKD) Recent Shelf Registration
|
|
Mannkind
|
Sep 06, 2012 10:51AM
|
|
Don’t Miss Out On The Huge Profits In Biotech Penny Stocks!
|
|
Mannkind
|
Jun 19, 2013 03:46PM
|
|
Does MannKind Have the Wrong Strategy?
|
|
Mannkind
|
Mar 12, 2013 05:27PM
|
|
Divine Skin Appoints Two New Independent Directors
|
|
Mannkind
|
Nov 28, 2012 04:06PM
|
|
Diane's at it again:
|
|
Mannkind
|
Jun 05, 2013 08:55PM
|
|
Diabetes Summit 2013 Organized by GTC Company
|
|
Mannkind
|
Feb 21, 2013 09:54AM
|
|
Diabetes prevention
|
3
|
Mannkind
|
Jul 05, 2012 09:54AM
|
|
Diabetes Drugs Market Will Reach $55.3bn in 2017, With Further Growth to 2023,
|
|
Mannkind
|
May 07, 2013 09:55AM
|
|
December,2013
|
|
Mannkind
|
Jul 14, 2013 10:20PM
|
|
Debt Burden Makes Horizon Pharma An Attractive Short
|
|
Mannkind
|
Jul 26, 2012 08:12AM
|
|
Debate on diabetes drugs gathers pace
|
|
Mannkind
|
Apr 30, 2012 01:46PM
|
|
Deals of the week:Tolero introduces itself in"double jointed" deal with MannKind
|
1
|
Mannkind
|
May 04, 2012 04:16PM
|
|
Cramer:
|
|
Mannkind
|
Mar 27, 2013 09:59AM
|
